Immune repertoire sequencing reveals systematic remodeling of T and B cell populations with age, with a critical inflection point around 60 years characterized by reduced clonal diversity and expanded hyperspecific clones. COVID-19 infection accelerates these aging signatures, suggesting the virus triggers biological immune senescence comparable to years of natural aging.
Key Points
- Immune diversity declines sharply after age 60 with reduced clonotype counts
- COVID-19 intensifies aging patterns: diminished diversity, expanded pathogen clones
- Machine learning model quantifies immune age acceleration post-infection
Longevity Analysis
The immune system's capacity to maintain a diverse, responsive repertoire is foundational to resistance against infection and age-related disease. This research demonstrates that immune senescence follows a measurable trajectory, and crucially, that acute viral infection can compress this timeline — essentially advancing biological age in the immune compartment independent of chronological time. The practical implication is two-fold: individuals can now assess their immune aging status with precision, and the magnitude of COVID-19's impact on immune aging establishes a quantifiable benchmark for understanding how other infections or inflammatory events may similarly accelerate deterioration in immune function. This shifts how we interpret long-term post-infection recovery and suggests that interventions to preserve immune diversity and clonal flexibility should be prioritized, particularly in those approaching or past the 60-year threshold where the system's resilience naturally attenu
Original published by Wiley Aging Cell, by Xin Gao, Si‐Jia Li, Jin Li, Zi‐Hui Wang, Lv‐Tao Zeng, Ya‐Qing Ma, Ya‐Min Dang, Ying‐Min Zhang, Hong‐Lei Liu, Li‐Qun Zhang, Jing Pang, Ju Cui, Tie‐Mei Zhang, Jian‐Ping Cai .